lamoncogroup.com
عن الشركة
The team at the Institute of Genomic Medicine at the University of California, San Diego determined that methylation was the best method to accurately detect cancers, and later developed the technology that is used in their laboratories today. In 2014, another team, led by Dr. Shu Li, formed Laboratory for Advanced Medicine to focus on the commercialization of methylation cancer detection testing with a US CLIA lab. Laboratory for Advanced Medicine (LAM) incorporates the efforts of those teams. The company has CLIA and CAP certified laboratories, and cGMP facilities working towards bringing first-class technologies to the medical community. LAM operates globally with collaborations in the United States and China, including leading scientists, physicians, research institutions, and business leaders. The company is headquartered in the United States with offices in California, Texas, and Indiana. In China, the company has offices in Beijing, Guangzhou and Bei Dai He.
شفافية الأعمال
- لم يتم التحقق من معلومات الشركة
- اطلب من عملائهم آراءهم
- لم يرد على المراجعات السلبية